These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 23479193)

  • 1. Synthesis and in-silico studies of some diaryltriazole derivatives as potential cyclooxygenase inhibitors.
    Radwan AA; elTahir KE
    Arch Pharm Res; 2013 May; 36(5):553-63. PubMed ID: 23479193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, anti-inflammatory activity and COX-1/COX-2 inhibition of novel substituted cyclic imides. Part 1: Molecular docking study.
    Abdel-Aziz AA; ElTahir KE; Asiri YA
    Eur J Med Chem; 2011 May; 46(5):1648-55. PubMed ID: 21388719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1-(4-Methoxyphenyl)-5-(3,4,5-trimethoxyphenyl)-1H-1,2,4-triazole-3-carboxamides: synthesis, molecular modeling, evaluation of their anti-inflammatory activity and ulcerogenicity.
    Abdel-Aziz M; Beshr EA; Abdel-Rahman IM; Ozadali K; Tan OU; Aly OM
    Eur J Med Chem; 2014 Apr; 77():155-65. PubMed ID: 24631895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, pharmacological screening and in silico studies of new class of Diclofenac analogues as a promising anti-inflammatory agents.
    Palkar MB; Singhai AS; Ronad PM; Vishwanathswamy AH; Boreddy TS; Veerapur VP; Shaikh MS; Rane RA; Karpoormath R
    Bioorg Med Chem; 2014 May; 22(10):2855-66. PubMed ID: 24751552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, biological evaluation and molecular modeling study of pyrazole derivatives as selective COX-2 inhibitors and anti-inflammatory agents.
    Tewari AK; Singh VP; Yadav P; Gupta G; Singh A; Goel RK; Shinde P; Mohan CG
    Bioorg Chem; 2014 Oct; 56():8-15. PubMed ID: 24893208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of 2,3-diaryl-1,3-thiazolidine-4-one derivatives as selective cyclooxygenase (COX-2) inhibitors.
    Zarghi A; Najafnia L; Daraee B; Dadrass OG; Hedayati M
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5634-7. PubMed ID: 17822894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of dithiolethiones as novel cyclooxygenase inhibitors.
    Zanatta SD; Manallack DT; Jarrott B; Williams SJ
    Bioorg Med Chem Lett; 2009 Jan; 19(2):459-61. PubMed ID: 19056264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, cyclooxygenase inhibition and biological evaluation of new 1,3,5-triaryl-4,5-dihydro-1H-pyrazole derivatives possessing amino/methanesulfonyl pharmacophore.
    Abdellatif KR; Fadaly WA
    Bioorg Chem; 2017 Feb; 70():57-66. PubMed ID: 27894776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of acyclic triaryl (Z)-olefins: a novel class of cyclooxygenase-2 (COX-2) inhibitors.
    Uddin MJ; Rao PN; Knaus EE
    Bioorg Med Chem; 2004 Nov; 12(22):5929-40. PubMed ID: 15498669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of antioxidant properties of some 6-(alpha-aminobenzyl)thiazolo[3,2-b]-1,2,4-triazole-5-ol compounds.
    Aktay G; Tozkoparan B; Ertan M
    J Enzyme Inhib Med Chem; 2009 Jun; 24(3):898-902. PubMed ID: 18951285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of 2-methyl-3-indolylacetic derivatives as anti-inflammatory agents that inhibit preferentially cyclooxygenase 1 without gastric damage.
    Perissutti E; Fiorino F; Renner C; Severino B; Roviezzo F; Sautebin L; Rossi A; Cirino G; Santagada V; Caliendo G
    J Med Chem; 2006 Dec; 49(26):7774-80. PubMed ID: 17181159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and cyclooxygenase inhibition of various (aryl-1,2,3-triazole-1-yl)-methanesulfonylphenyl derivatives.
    Wuest F; Tang X; Kniess T; Pietzsch J; Suresh M
    Bioorg Med Chem; 2009 Feb; 17(3):1146-51. PubMed ID: 19157881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indole based cyclooxygenase inhibitors: synthesis, biological evaluation, docking and NMR screening.
    Estevão MS; Carvalho LC; Freitas M; Gomes A; Viegas A; Manso J; Erhardt S; Fernandes E; Cabrita EJ; Marques MM
    Eur J Med Chem; 2012 Aug; 54():823-33. PubMed ID: 22796043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diarylheterocycle core ring features effect in selective COX-1 inhibition.
    Perrone MG; Vitale P; Malerba P; Altomare A; Rizzi R; Lavecchia A; Di Giovanni C; Novellino E; Scilimati A
    ChemMedChem; 2012 Apr; 7(4):629-41. PubMed ID: 22278975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel quinoline incorporating 1,2,4-triazole/oxime hybrids: Synthesis, molecular docking, anti-inflammatory, COX inhibition, ulceroginicity and histopathological investigations.
    Mohassab AM; Hassan HA; Abdelhamid D; Abdel-Aziz M; Dalby KN; Kaoud TS
    Bioorg Chem; 2017 Dec; 75():242-259. PubMed ID: 29032325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, pharmacological characterization, and docking analysis of a novel family of diarylisoxazoles as highly selective cyclooxygenase-1 (COX-1) inhibitors.
    Vitale P; Tacconelli S; Perrone MG; Malerba P; Simone L; Scilimati A; Lavecchia A; Dovizio M; Marcantoni E; Bruno A; Patrignani P
    J Med Chem; 2013 Jun; 56(11):4277-99. PubMed ID: 23651359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of new 4-phenylpyrimidine-2(1H)-thiones and their potency to inhibit COX-1 and COX-2.
    Seebacher W; Faist J; Presser A; Weis R; Saf R; Kaserer T; Temml V; Schuster D; Ortmann S; Otto N; Bauer R
    Eur J Med Chem; 2015 Aug; 101():552-9. PubMed ID: 26197159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and cyclooxygenase inhibitory activities of some N-acylhydrazone derivatives of isoxazolo[4,5-d]pyridazin-4(5H)-ones.
    Unsal-Tan O; Ozden K; Rauk A; Balkan A
    Eur J Med Chem; 2010 Jun; 45(6):2345-52. PubMed ID: 20207453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and structure-activity relationship studies of 1,3-diarylprop-2-yn-1-ones: dual inhibitors of cyclooxygenases and lipoxygenases.
    Rao PN; Chen QH; Knaus EE
    J Med Chem; 2006 Mar; 49(5):1668-83. PubMed ID: 16509583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and anti-inflammatory evaluation of novel diphenylthiazole-thiazolidinone hybrids.
    Abdelazeem AH; Salama SA; Maghrabi IA
    Arch Pharm (Weinheim); 2015 Jul; 348(7):518-30. PubMed ID: 25989149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.